Skip to main content

10 Result(s)

within Article Remove this filter D Porter Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood

    For many cancers, adolescents and young adults (AYA) have worse outcomes than for children and adults. Many factors may contribute to the AYA survival gap, including differences in biology, therapeutic intent,...

    Z. Liu, J. Martin, L. Orme, B. Seddon, J. Desai… in Cancer Chemotherapy and Pharmacology (2018)

  2. Article

    Open Access

    Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

    The original article contains several small errors. The errors & concurrent corrections are listed below [1]:

    D. Porter, N. Frey, P. A. Wood, Y. Weng, S. A. Grupp in Journal of Hematology & Oncology (2018)

    Download PDF (245 KB) View Article

  3. No Access

    Article

    Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review

    Aromatase inhibitors (AIs) decrease the production of oestrogen, decreasing stimulation of hormone receptor-positive breast cancer. Theoretically, AIs may be less effective in obese women, due to the greater q...

    S. J. Ioannides, P. L. Barlow, J. M. Elwood… in Breast Cancer Research and Treatment (2014)

  4. No Access

    Article

    Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations

    Uveal melanoma (UM) is a genetically and biologically distinct type of melanoma, and once metastatic there is no effective treatment currently available. Eighty percent of UMs harbor mutations in the Gαq family m...

    X Chen, Q Wu, L Tan, D Porter, M J Jager, C Emery, B C Bastian in Oncogene (2014)

  5. Article

    Erratum: Smac mimetics: implications for enhancement of targeted therapies in leukemia

    Correction to: Leukemia (2010) 25, 2100–2109; doi:10.1038/leu.2010.212 Owing to a typesetting error, the following sentence was incorrectly printed in the abstract section of the article: ‘The novel inhibitor ...

    E Weisberg, A Ray, R Barrett, E Nelson, A L Christie, D Porter, C Straub… in Leukemia (2011)

    Download PDF (90 KB) View Article

  6. No Access

    Article

    Smac mimetics: implications for enhancement of targeted therapies in leukemia

    Drug resistance is a growing concern with clinical use of tyrosine kinase inhibitors. Utilizing in vitro models of intrinsic drug resistance and stromal-mediated chemoresistance, as well as functional mouse model...

    E Weisberg, A Ray, R Barrett, E Nelson, A L Christie, D Porter, C Straub… in Leukemia (2010)

  7. Article

    HIN-1, an inhibitor of cell growth, invasion, and AKT1 activation

    IE Krop, MT Parker, N Qimron, D Porter, K Polyak in Breast Cancer Research (2005)

    Download PDF (1272 KB) View Article

  8. Article

    Open Access

    Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports

    Interactions between phenytoin and the fluoropyrimidine derivatives, 5 fluorouracil (5FU) and capecitabine, are not commonly documented or widely recognised. As more people with significant medical comorbiditi...

    K Brickell, D Porter, P Thompson in British Journal of Cancer (2003)

    Download PDF (73 KB) View Article

  9. No Access

    Article

    Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy

    Nonmyeloablative allogeneic stem cell transplantation (NMASCT) can be used to exploit the graft-versus-tumor (GVT) potential of allogeneic donor cells in the setting of reduced conditioning regimen toxicity. ...

    R. Buckanovich, G. Liu, C. Stricker, S. Luger, E. Stadtmauer… in Annals of Hematology (2002)

  10. No Access

    Article

    Constitutional p53 mutation in a non-Li-Fraumeni cancer family

    J Prosser, D Porter, C Coles, A Condie, AM Thompson, U Chetty… in British Journal of Cancer (1992)